Evidence-Based Management and Treatment of Outpatient Community-Associated MRSA
Abstract
There is evidence of a growing incidence of resistant microorganisms in the United States, and nurse practitioners (NPs) are in a pivotal position to lead in the delivery of health care related to this problem. Recently, the incidence of community-associated methicillin-resistant Staphylococcus aureus has increased, which requires urgent attention to safe practice and prevention. Because this is a relatively new public health problem, the evidence to support management is evolving. NPs are positioned to examine the evidence and incorporate findings into practice.
In compliance with national ethical guidelines, the authors report no relationships with business or industry that would pose a conflict of interest.
1Janis R. Guilbeau, DNP(c), FNP-BC, is a family nurse practitioner and instructor at the University of Louisiana at Lafayette and DNP candidate at the University of Alabama at Birmingham.
2Pamela N. Fordham, DSN, CRNP, FAANP, is assistant professor, chair of family/child health and caregiving, and project director of the palliative care NP program at the University of Alabama School of Nursing. She is also the deputy director of the UAB Center for Palliative Care.